1. Introduction {#sec0001}
===============

CH~4~ is the second largest anthropogenic greenhouse gas and its global warming potential is 25 times more than that of CO~2~ ([@bib0030]; [@bib0009a]). The US-Energy Protection Agency (EPA) stated that China, India, the United States, Brazil, Russia, Mexico, Ukraine and Australia are the major CH~4~ emitters in the world. CH~4~ emission is projected to increase by 15% to 7904 MMT (Million Metric Ton)-CO~2~Eq. by 2020 ([@bib0004a]). About 25% of enteric CH~4~ emission accounted globally from the ruminants represents a loss of 5--7% of dietary energy ([@bib0044], [@bib0100]).

A total CH~4~ emission is estimated to be 163.3 MMT-CO~2~ Eq. from enteric fermentation and 61.2 MM-TCO~2~ Eq. from manure management (US-EPA, 2014). Beef (116.7 MMT-CO~2~ Eq.) and dairy cattle (41.6 MMT-CO~2~ Eq.) are being as main sources for enteric CH~4~ emission ([Table 1](#tbl0001){ref-type="table"}). The management of manure from anaerobic digester (61.2 MMT-CO~2~ Eq.), dairy cattle (32.2 MMT-CO~2~ Eq.) and swine (22.4 MMT-CO~2~ Eq.) is also contributed to global CH~4~ emission. Cattle (77.3 kg × 10^6^) and buffalo (12.1 kg × 10^6^) will be the major source for the projected global CH~4~ emission from enteric fermentation in 2025. CH~4~ emission budget (105 kg ×10^6^) will be 107 times more from manure management (12,849 kg ×10^6^) ([Table 2](#tbl0002){ref-type="table"}). Hence, reducing CH~4~ emissions from ruminants is not only benefits for the environment, but also to ensure the long-term sustainability of ruminant-based agriculture ([@bib0120]).Table 1CH~4~ emissions (MMT-CO~2~ Eq.) from ruminant-based agriculture (US EPA report 2016).Table 1Gas/Livestock200520102011201220132014EFMMEFMMEFMMEFMMEFMMEFMMBeef cattle125.23.3124.63.3121.83.3119.13.21183116.73Anaerobic digester\*--56.3--60.9--61.5--63.7--61.4--61.2Dairy cattle37.626.440.730.441.131.141.732.641.631.841.932.2Poultry--3.2--3.2--3.2--3.2--3.2--3.2Horses2.30.32.40.22.50.22.50.22.50.22.40.2Sheep1.70.11.70.11.70.11.60.11.60.11.60.1Swine1.222.91.123.61.123.61.124.31.123122.4Goats0.4--0.4--0.3--0.3--0.3--0.3--American bison0.4--0.4--0.3--0.3--0.3--0.3--Mules and asses0.1--0.1--0.1--0.1--0.1--0.1--Gross total168.956.3171.360.9168.961.5166.763.7165.561.4164.361.2[^1][^2]Table 2The projected CH~4~ emissions (kg ×10^6^) in the year of 2025 from ruminant-based agriculture.Table 2LivestockEnteric fermentationManure managementCattle77.37002Buffalo12.1933Sheep6.18183Goat5.19222Swine1.293700Poultry--537Camel1.1762Horse1.03--Ass0.4540Mule0.099Alpaca0.1386Total10512,849

1.1. Rumen microbiota {#sec0002}
---------------------

The typical rumen microbiota consists of 10--50 billion bacteria, 1 million protozoa and variable numbers of yeasts and fungi in each milliliter of rumen content ([@bib0026]). Anaerobic microbes are degrading polysaccharides (cellulose, hemicellulose, starch and pectin), proteins, and lipids from food/feed and of producing organic acids (formate, pyruvate, acetate, propionate, butyrate, and succinate) from which CH~4~ gas is produced by rumen methanogenic archaea ([@bib0017]). The rumen microbes rapidly ferment amino acids and soluble proteins and form various acidic fermentation products (NH~3~, H~2~ and CO~2~). The turnover rate of fermentation products cannot be measured due to exchange reactions across the microorganisms ([@bib0003]). Pyruvate produced from anaerobes is carboxylated to form oxaloacetate and further converted to malate, fumarate and succinate. The rumen microbes that are not producing succinate can use CO~2~ as a sole carbon source ([@bib0104]). Gut microbiota are able to synthesis indispensable amino acids and vitamins from the non-protein nitrogen sources and offer them as nutrient supplements to the host animal ([@bib0077]). These processes clearly indicate that the rumen is a dynamic ecosystem wherein the gut microbiota may interact and support one another in a complex food web.

1.2. Rumen methanogenic archaea {#sec0003}
-------------------------------

Methanogenic archaea are capable of producing CH~4~ from the low carbon substrates such as formate, pyruvate, methylamine, acetate, and CO~2~ through methanogenesis. This process depends on the availability of ATP derived from enteric fermentation of rumen anaerobic bacteria ([@bib0006], [@bib0042]). The overall effects of methanogenic archaea play a crucial role in the physiology and health of the ruminants ([@bib0022]). *Methanomicrobium mobile, Methanobacterium lacus, Methanobacterium formicicum* (MFI), *Methanomicrobium bryantii, Methanobrevibacter ruminantium, Methanobrevibacter smithi, Methanosarcina barkeri* and *Methanosarcina mazei* are culturable rumen methanogenic archaea have been studied in detail ([@bib0041]). Methanobacterium and Methanobrevibacter are predominant genera usually inhabited in the rumen ecosystem.

2. Methanobacterium formicicum {#sec0004}
==============================

MFI is a representative species of methanogenic archaea found in the gut of ruminants and humans ([@bib0081], [@bib0094]). This microorganism can utilize CO~2~ with H~2~, fermented by-products of the rumen bacteria, for CH~4~ production in rumen gut environment. CO~2~ is released by the animal into the atmosphere. MFI is a clinically important microorganism because it can cause gastrointestinal and metabolic disorders in animals and humans ([@bib0052], [@bib0073]). This microorganism is able to ferment acetate, carbohydrate, amino acid, ethanol, methanol, propionate, butyrate and lactate. MFI contains all essential genes need for methanogenic process with exception of \[Fe\]-hydrogenase dehydrogenase (*hmd*). Both CH~4~ production and formate consumption are linear functions of its growth rate. The molar growth yield of MFI for CH~4~ of formate cultures is 4.8 g dry weight per mol, and that of H~2~---CO~2~ culture was 3.5 g dry weight per mol ([@bib0086]). Pseudomurein and polysaccharide biosynthesis genes are similar to those found in *M. ruminantium* ([@bib0058]). MFI strain BRM9 does not have homologs of N-acylneuraminatecytidyl transferase coding genes (*neuA*/*neuB*) as in the strain DSM 3637 ([@bib0050]). MFI consists of 3 ectoine biosynthetic genes usually existed in halo-tolerant microorganisms, but ectoine is not yet reported to be produced by methanogenic archaea ([@bib0065], [@bib0074]). The genome of this microorganism contains a large number of genes for two-component signal transduction system. This system helps to monitor the changes in the redox potential, oxygen and overall cellular energy level of MFI ([@bib0099]). It has a characteristic metabolism of nitrogen, particularly in ammonium transporters and glutamine synthase/glutamate synthase pathway.

2.1. Genomic features {#sec0005}
---------------------

Currently, 7 complete genome sequences are available for different species of Methanobacterium and Methanobrevibacter ([@bib0039], [@bib0058], [@bib0059]) ([Fig. 1](#fig0001){ref-type="fig"}; [@bib0071]a). Researchers have identified 3 different strains (DSM3637, DSM1535 and BRM9) of MFI from the bovine rumen ([@bib0052], [@bib0071], [@bib0070]). Comparison of 16S rRNA gene sequences indicate 99.8% sequence similarity between strain BRM9 and strain DSM1535 ([@bib0013]). MFI strain KOR-1 strain isolated from an anaerobic digester using pig slurry has shown 98% rRNA gene and 97% *mcrA* gene sequence similarities to other strains ([@bib0008]). The genome of strain DSM3637 (2.47 Mbp) comprises of a total of 2556 protein-coding genes in which 643 proteins assigned to be hypothetical proteins ([@bib0039]). The strain DSM1535 is 2.4 Mbp in genome size with 41.23% GC content and encoded for several adaptation genes responsible for abiotic stress ([@bib0070]). The BRM9 strain consists of a single 2.44 Mbp circular chromosome with 2352 protein coding genes (83%). A putative function is assigned to 1715 of the protein-coding genes, with the remainder annotated as hypothetical proteins ([@bib0052]). Conserved hypothetical proteins are ranged from 413 to 736 in the genera of Methanobacterium and Methanobrevibacter.Fig. 1Genome-scale metabolic information of MFI and related rumen methanogens, collected from the MetaCyc database (<https://metacyc.org/>). We compared genome (a), metabolome (b), anabolism (c) and catabolism (d) to infer genomic similarities and dissimilarities across them. (MEL: *Methanobacterium lacus*, MEW: *Methanobacterium* sp. SWAN-1, METH: *Methanobacterium s*p.MB1, MSI: *Methanobrevibacter smithii*, MRU: *Methanobrevibacter ruminantium*, MEB: *Methanobrevibacter* sp. AbM4).Fig 1

2.2. Transcription regulatory systems {#sec0006}
-------------------------------------

The MFI genome possesses a maximum number of transcription units compared to the genera of Methanobacterium and Methanobrevibacter ([@bib0052], [@bib0053], [@bib0117]). Transcriptional regulation of coenzyme F~420~-dependent formate dehydrogenase (*fdhCAB*) ([@bib0078], [@bib0087], [@bib0112]), glyceraldehyde-3-phosphate dehydrogenase ([@bib0028]), archaeal histones (*hfoAB*) ([@bib0020], [@bib0122]) has been extensively characterized in this microorganism. *NrpR* is a transcriptional regulator that represses transcription of nitrogen fixation genes, glutamine synthase and ammonium transporters. This regulator binds to inverted repeat operators in the promoter regions located upstream from the starts of *glnA,nifH, pdxT, amt1* and *amt2* ([@bib0003], [@bib0062], [@bib0066]). MFI contains *nif* operon, nitrogenase and nitrogenase cofactor biosynthesis genes as similar to *Methanococcus maripaludis* ([@bib0062], [@bib0066]). An intensive analysis of the current genomic data of MFI provided a new avenue for the development of veterinary vaccines and small-molecule inhibitors for CH~4~ mitigation ([@bib0060], [@bib0109]). Hence, the MFI genome is considered as a suitable candidate for studying systems biological characterization of rumen methanogens. Such systems-level information is currently useful to discover new veterinary vaccines and chemogenomic targets for new CH~4~ mitigation interventions ([@bib0010], [@bib0088]).

2.3. Metabolic regulatory systems {#sec0007}
---------------------------------

Metabolic pathway data including reactions, enzymes, and metabolites provide insight into the growth and metabolic physiology of MFI ([Fig. 1](#fig0001){ref-type="fig"}b). This genome consists of abundant genes for the biosynthesis of carbohydrate and nucleotides ([Fig. 1](#fig0001){ref-type="fig"}c). Genes involved in anabolism of this microorganism are considerably lower than that of other species in Methanobacterium genus, indicative of a characteristic system exists for carbohydrate biosynthesis. It has been well-established that systems for catabolism of amino acids and nucleic acids, which are relatively low to related genera ([Fig. 1](#fig0001){ref-type="fig"}d). *Methanobacterium lacus* and *Methanobacterium* sp. SWAN-1 have 5 more additional genes for energetic CH~4~ biosynthesis, compared to the MFI genome. MFI is a target rumen methanogen for the development of new CH~4~ mitigation interventions owing to the existence of conserved nature of genes required for methanogenesis, central metabolism and Pseudomurein cell wall formation ([@bib0052]).

2.4. Gut microbial symbiosis {#sec0008}
----------------------------

Gut microbiota are shaped by both genetic background and lifestyle, which in turns impairs intestinal barrier function ([@bib0014], [@bib0097]) and modulates epithelial cell proliferation ([@bib0095]) and metabolic inflammation ([@bib0097]). It is well known that healthy gut microbiota are essential one to protect against the pathogenic microorganisms in the intestine ([@bib0101]) and modulate gut-brain axis ([@bib0045]). Several studies have focused on the metabolic crosstalk between gut microbiota and host to reveal the metabolic disorders of human ([@bib0014], [@bib0015], [@bib0054], [@bib0097]), but none has been reported for animals. A gut microbial composition may restrict the production of certain bacterial metabolites ([@bib0040]). Microbial mutualism can occur through metabolic interactions between host and gut microbe and between microbe and microbe ([@bib0007], [@bib0076]). Endo-symbiotic methanogenic archaea are usually habituated in the gastrointestinal tracts of ruminants, which are contributing in the syntrophic degradation and improved metabolic function. MFI is an endosymbiotic methanogenic archaea of free-living anaerobic flagellate *Psalteriomonas vulgaris* ([@bib0012]) associating syntrophically with *Syntrophomonas zehnderi* ([@bib0096]).

2.5. H~2~ scavenging systems {#sec0009}
----------------------------

Interspecies H~2~ transfer is a metabolic process occurring between hydrogenotrophic methanogenic archaea and cellulolytic/acetogenic bacteria. Hydrogenotrophic methanogenic archaea maintain the partial pressure of H~2~ by utilizing H~2~ produced by cellulolytic bacteria. *Ruminococcus albus* and *R. flavefaciens* are H~2~-producing cellulolytic anaerobe for interspecies H~2~ transfer of MFI ([@bib0016], [@bib0049], [@bib0080], [@bib0113], [@bib0116]). *Fibrobacter succinogenes, Wolinella succinogenes* and *Mitsuokella jalaludinii* are fumarate reducing rumen anaerobic bacteria. These microorganisms are able to reduce CH~4~ production either by competing with hydrogenotrophic methanogenic archaea for H~2~ as well as formate or by increasing succinate ([@bib0005], [@bib0068], [@bib0067]). Therefore, cellulolytic and fumarate reducing bacteria are extensively studied symbiotic anaerobes for interspecies H~2~ transfer of MFI. Comparative metabolic analysis shows that 237 metabolic enzymes are shared across the MFI, *F. succinogens* and *R. albus* and 210 enzymes are common between *F. succinogens* and *R. albus*([Fig. 2](#fig0002){ref-type="fig"}). MFI has 126 unique enzymes across *F. succinogens* and *R. albus*, 38 enzymes shared with *R. albus* and 44 enzymes with *F. succinogens*. Hence, studying metabolic symbiosis of these genomes is important to comprehend the gut physiology and metabolic disorders of veterinary animals.Fig. 2Comparison of metabolic enzymes sharing across MFI, *F. succinogens* and *R. albus*. Complete metabolic enzymes (E.C.) were collected from the MetaCyc database (<https://metacyc.org/>), compared and then viewd in Venn diagram.Fig 2

3. Systems biology paradigm {#sec0010}
===========================

The biochemical function of individual genes and proteins of microorganisms has been investigated by traditional molecular approaches. A complexity of microbial symbiosis and metabolic crosstalk has been reconciled by recent quantitative systems biology advances. Genome-scale metabolic models are being as the promising computational platforms for studying intracellular metabolism and interspecies interactions of microbial communities and for hypotheis testing ([@bib0064]).

3.1. Genome-scale reconstructions for methanogenic archaea {#sec0011}
----------------------------------------------------------

Systematic analysis of methanogenic archaea and mutualistic anaerobic bacteria provides an opportunity to capture growth parameters and bacterial community composition ([@bib0024], [@bib0098]). *In silico* models for *M. barkeri* (iAF692; iMG746) ([@bib0029], [@bib0036]), *M. acetivorans* (iMB745; iVS941) ([@bib0009], [@bib0057]) and *Methanococcus maripaludis* (iMM518) ([@bib0038]) have been previously developed for studying their metabolic behaviors on different growth substrates. In addition to that, a metabolic flux model has been reconstructed for understanding a microbial mutualism between *M. maripaludis* ([@bib0038]) and *Desulfovibrio vulgaris* ([@bib0098]).

3.2. Genome-scale reconstructions for gut-microbe interactions {#sec0012}
--------------------------------------------------------------

Several genome-scale models have been developed for evaluating the mechanistic details of gut-microbe interactions ([@bib0023], [@bib0032], [@bib0085], [@bib0089], [@bib0091], [@bib0090]) and host-microbe metabolic symbiosis ([@bib0040], [@bib0048], [@bib0093]). PHIDIAS ([@bib0119]), HPIDB ([@bib0055]), PHISTO ([@bib0025]), PATRIC ([@bib0108]), PHI-base ([@bib0106]), CASINO ([@bib0090]), HMI™ module ([@bib0069]), and NetCooperate ([@bib0061]) are web-based tools and databases accessible for studying the microbe-microbe, diet-microbe and microbe-host interactions. GeoSymbio ([@bib0031]) and SymbioGenomesDB ([@bib0084]) are specialized computational resources developed for learning the host-microbiome interactions and microbial symbiosis ([Table 3](#tbl0003){ref-type="table"}).Table 3Systems biology tools and databases used for studying microbial mutualism in the gut environments.Table 3ToolPurposeReferencePHIDIASMolecular functions of pathogen and host genes[@bib0119])HPIDBMicrobial infections and drug targets discovery[@bib0119])GeoSymbioSymbiodinium-host symbioses[@bib0031])PHISTOTherapeutic targets discovery for microbial infections[@bib0025])PATRICComparative genomic or transcriptomic analysis[@bib0108])HMI™ moduleMechanistic understanding of host-microbiome interactions[@bib0069])PHI-baseCatalogues experimentally verified molecular virulence factors[@bib0106])CASINOAnalysis of microbial communities through metabolic modeling[@bib0090])NetCooperateHost-microbe and microbe-microbe cooperation[@bib0061])SymbioGenomesDBHost-symbiont relationships[@bib0084])

4. CH~4~ mitigation interventions {#sec0013}
=================================

CH~4~ mitigation stratagies should ideally target features that are conserved across all rumen methanogenic archaea. Consequently, other beneficial anaerobes continue their normal digestive functions in the ruminants ([@bib0037], [@bib0111]). Several CH~4~ mitigation interventions have been investigated such as change in dietary composition like use of fatty acids ([@bib0002]), tannin ([@bib0056]), monensin ([@bib0111]), plant extracts ([@bib0035], [@bib0094]), fumarate and chemical inhibitors ([@bib0019], [@bib0072]; [@bib0103]), and anti-methanogenic vaccines ([@bib0110], [@bib0114]). So far, only a small percentage of CH~4~ mitigation has been successfully implemented by dietary changing. Some chemical inhibitors have been investigated to destroy the pathogenic bacteria, and those inhibitors may be beneficial to the host, which in turn affects the rumen microbiota. Thus, it is important to access the effect of methanogenic inhibitors on the stability of rumen healthy microbiota and also to discover new chemogenomic targets for CH~4~ mitigation.

4.1. Methanogenic antibiotics and inhibitors {#sec0014}
--------------------------------------------

Chemical inhibitors or enzymes targeting essential functions of methanogenic archaea are delivered via slow-release capsules administered to the rumen. Neomycin, pseudomonic acid ([@bib0011], [@bib0047]), puromycin ([@bib0033]), 8-aza-2, 6-diaminopurine ([@bib0083]) and 8-aza-hypoxanthine ([@bib0075]) are methanogenic antibiotics, and inhibitors are presently used against *M. mariplaudis* and *M. barkeri*. Ethyl 2-butynoate, lovastatin, mevastatin, fluoroacetate, chloroform, 2-bromoethanesulphonate, and 2-nitroethanol are potential methanogenic inhibitors investigated to inhibit the methanogenesis of Methanobrevibacter and Methanobacterium ([@bib0019], [@bib0072], [@bib0103]). The growth of methanogenic archaea and persistence of 2-bromoethanesulfonate resistance increased with administration of it in bovine ([@bib0107]). *M. ruminantium, M. mazei* and *M. mobile* found to be resistant to 3-bromopropanesulfonate up to 250 μmol/L in pure cultures ([@bib0103]). Therefore, it is consistent with the limited efficacy of 2-bromoethanesulfonate and 3-bromopropanesulfonate in lowering CH~4~ production by rumen microbiome ([@bib0051], [@bib0079]).

Monensin inhibits the methanogenesis from formate, but not from H~2~---CO~2~ in ruminants ([@bib0021]). Bovine somatotrophin, monensin and lasalocid have been extensively used in beef and cattle farming to improve growth rates ([@bib0001], [@bib0004], [@bib0027]). Monensin affects electrolyte transport of methanogenic and propionate-producing bacteria. It also inhibits some bacteria responsible for proteolysis and deamination. A long term supplementation of monensin does not have an implementation in CH~4~ reduction efficacy ([@bib0043]). Interestingly, Thermoplasmata archaea are methylotrophic (methylamine degrading) methanogens found in bovine rumen, which are able to mitigate methane emissions from lactating cows upon dietary supplementation with rapeseed oil ([@bib0082]). Thus, methanogenic inhibitors have been investigated in regard to their affect on the total population of Methanobacterium, Methanobrevibacter, Methanosphaera and Thermoplasmata making unbalanced microbial ecosystem in the rumen gut ([@bib0115], [@bib0121], [@bib0123]).

4.2. Chemogenomic targets {#sec0015}
-------------------------

Generally, methanogenic antibiotics and inhibitors that target the key enzymes involved in the biosynthesis of cell wall, protein, vitamins and cofactors of MFI. Hydroxymethylglutaryl-SCoA reductase, aconitase, coenzyme M are common targets for many methanogenic inhibitors ([@bib0019], [@bib0072], [@bib0103]) ([Table 4](#tbl0004){ref-type="table"}; Supplementary). Some of the methanogenic inhibitors have shown to decrease the proton gradient across the membrane, loss of digestible energy for ruminants, regulation of formate and H~2~ oxidation, carbohydrate-fermentation and acetate metabolism ([@bib0018], [@bib0019], [@bib0063], [@bib0121], [@bib0103]). However, the inhibitory effect is lost or reverted following long term administration in ruminants. It suggests the discovery of new therapeutic targets to be intended to resolve such crises.Table 4Methanogenic antibiotics and inhibitors used for reducing enteric methane emission from Methanobacterium and Methanobrevibacter genera resident in ruminants.Table 4CompoundConc. (mM/ml)CH~4~ inhibition (%)Targets to be inhibited2-Nitroethanol0.01299Formate and H~2~ oxidationSodium nitrate0.01270Alternative electron acceptorsAcetylene7.2e^−6^50Proton gradient across the membraneEthylene1e^−4^50Proton gradient across the membrane2-Bromoethanesulphonate0.00025100Coenzyme MPropynoic acid0.00496Carbohydrate-fermentation pathwayEthyl 2-butynoate0.008100Loss of digestible energy for ruminantsLovastatin1e^−5^100Hydroxymethylglutaryl-SCoAreductaseMevastatin5.8e^−6^100Hydroxymethylglutaryl-SCoAreductaseFluoroacetate0.001100AconitaseChloroform0.1100Acetate metabolismMonensin5.9e^−5^83Loss of digestible energy for ruminantslasalocid6.7e^−5^89Loss of digestible energy for ruminants

4.3. Veterinary vaccination {#sec0016}
---------------------------

Immunization is one of the novel CH~4~ mitigation stratagies in which the animals acquire immunity against a particular rumen methanogenic Archaean ([@bib0046], [@bib0073], [@bib0102]). When animals are vaccinated, salivary antibodies are produced in the animal against rumen methanogenic archaea. A vaccine developed against *Streptococcus bovis* and *Lactobacillus* species causes a lactic acidosis, which elicits an immune response against rumen methanogenic archaea ([@bib0034], [@bib0092]). Using VF3 and VF7 antigens, anti-methanogenic vaccines have been investigated for the reduction of CH~4~ emission from enteric fermentation ([@bib0114], [@bib0118]). Vaccination of sheep with methanogenic archaeal fractions has been developed for effective CH~4~ mitigation ([@bib0109]). Genome sequence of *M. ruminantium* M1 was compared with closely related methanogenic archaea to identify conserved methanogen surface proteins as suitable candidates for the development of vaccines ([@bib0058]). Energy metabolism (EC 2.1.1.86, 3.6.3.14), protein fate (EC 3.4.23.43) and adhesion/cell surface proteins are identified as vaccine targets for MFI ([Table 5](#tbl0005){ref-type="table"}; Supplementary). Yet, new CH~4~ mitigation interventions should be addressed in the development of alternative veterinary vaccines against MFI. Any veterinary vaccine should be targeted methanogen-specific proteins and should not affect the growth of other beneficial microorganisms, which can be resolved by systems-biology approach.Table 5Chemogenomic and vaccine targets identified in *M. formicicum* formethane mitigation.Table 5MetabolismGene/Locus tagECMolecular functionAmino acid metabolismRS111004.2.3.43-Dehydroquinate synthaseRS029452.5.1.193-Phosphoshikimate 1-carboxyvinyltransferaseRS014704.1.1.20Diaminopimelate decarboxylaseCell cycleRS05130\| RS051355.99.1.3DNA topoisomerase VI subunit ABCell envelop*glmU*2.3.1.157Glucosamine-1-phosphate N-acetyltransferase*glmU*2.7.7.23UDP-N-acetylglucosaminediphosphorylaseCentral carbon metabolism*sdhA*/RS124651.3.5.1Succinate dehydrogenaseRS073801.5.98.25,10-methylenetetrahydromethanopterin reductaseRS017701.5.98.1Methylenetetrahydromethanopterin dehydrogenaseRS10770\| RS004402.3.1.101Formylmethanofuran--tetrahydromethanopterinformyltransferaseRS096053.5.4.27N(5),N(10)-methenyltetrahydromethanopterincyclohydrolaseRS09415\| RS09420\| RS09425\| RS09430\| RS09435\| RS07735\| RS00350\| RS00355\| RS00360\| RS003652.8.4.1Coenzyme-B sulfoethylthiotransferaseRS09460\| RS09455\| RS09450\| RS09445\| RS09440\| RS09465\| RS09470\| RS094752.1.1.86Tetrahydromethanopterin S-methyltransferase subunit ABCDEFGHRS01320\|RS024801.2.99.5Formylmethanofuran dehydrogenase subunit ELipid metabolism*ubiA*\|RS11985\|RS06695\|RS06235\|RS06250\|RS029252.5.1.1DimethylallyltranstransferaseRS054855.3.3.2Isopentenyl pyrophosphate isomeraseProtein biosynthesisRS10560\|RS04105\|RS041106.3.5.6Asparaginyl-tRNA synthase subunit CDERS01925\|RS09115\|RS10560\|RS04105\|RS041106.3.5.7Glutaminyl-tRNA synthase subunit ABCDEVitamins and cofactorsRS103352.4.2.52Triphosphoribosyl-dephospho-CoA synthaseEnergy metabolismRS06810\|RS06805\|RS06820\|RS06800\|RS06825\|RS06815\|RS06835\|RS068303.6.3.14\*ATP synthase subunit ABCDFIK*selD*2.7.9.3Selenide, water dikinase*bcrA, bcrB, bcrC, bcrD*1.3.7.8Benzoyl-CoA reductaseRS09460\| RS09455\| RS09450\| RS09445\| RS09440\| RS09465\| RS09470\| RS094752.1.1.86\*Tetrahydromethanopterin S-methyltransferase subunit ABCDEFGHProtein fate*gspO*3.4.23.43\*Prepilin peptidase[^3]

5. Conclusions {#sec0017}
==============

Grazing ruminant animals are important contributors to the CH~4~ pool and account for 25% of greenhouse gas emission in the world. A genome-scale metabolic network of MFI could be reconstructed to elucidate its metabolic symbiosis across the gut microbiota and host. The mechanisms underlying syntrophic and competitive behaviors of this microorganism can be explored with experiment-driven molecular hypotheses. Metabolic modeling process may serve as a platform to discover and prioritize the potential chemogenomic and vaccine targets from MFI for CH~4~ mitigation interventions. To resolve this issue effectively at the systems-scale, we should address the following questions; 1. What are the key metabolites to be produced from MFI to ensure its growth and methanogenesis in a rumen ecosystem? 2. How does the core metabolic network of MFI determined its symbiotic behavior across the physiologically distinct anaerobes? and 3. How is MFI interacting with gut microbiota via metabolic crosstalk in response to microbial symbiosis, drugs and nutrients?

The development of CH~4~ mitigation interventions is a great concern for improving animal production efficiency because of the demand for increased meat and milk products. The H~2~ scavenging action of MFI is an essential function, since it prevents accumulation of H~2~ produced as a result of enteric fermentation. Moreover, it is imperative for us to know that if the rumen methanogenic archaea are inhibited, what would be the alternate ways in which to reduce the accumualtion of H~2~. Metabolic symbiosis of MFI in response to different environmental stimuli has resulted from the action of syntrophic and competitive bacteria in the ruminants, and it is important to understand its growth physiology in the gut environment. CH~4~ mitigation strategies should be developed, but without affecting the beneficial rumen microbiome and microbiota, and without compromise to the digestive function of ruminants. Methanogenic antibiotics, inhibitors and vaccines have been narrow spectrum and species-specific activity, reflecting the demand for the potential target discovery for wide-range of methanogenic archaea.
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[^1]: \*Accounts for CH~4~ reductions due to capture and destruction of CH~4~ at facilities using anaerobic digesters.

[^2]: EF: Enteric fermentation; MM: Manure management.

[^3]: \*Vaccine targets
